Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest update is out from Cochlear Limited ( (AU:COH) ).
Cochlear Limited has announced an update regarding its ongoing on-market buy-back of ordinary shares, with a total of 3,000 shares bought back on the previous day, bringing the total to 69,300 shares. This buy-back reflects Cochlear’s strategic efforts to manage its capital structure and potentially enhance shareholder value.
More about Cochlear Limited
Cochlear Limited operates in the medical device industry, specializing in hearing implant solutions. Its primary products include cochlear implants used to treat moderate to profound hearing loss, and the company focuses on serving both pediatric and adult patients globally.
YTD Price Performance: -8.54%
Average Trading Volume: 90
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $11.41B
See more insights into COH stock on TipRanks’ Stock Analysis page.
